Mitchell S. Kapoor Analyst PerformanceAnalyst at HC WainwrightMitchell S. Kapoor is a stock analyst at HC Wainwright focused in the healthcare sector, covering 32 publicly traded companies. Over the past year, Mitchell S. Kapoor has issued 124 stock ratings, including buy, hold, and sell recommendations. While full access to Mitchell S. Kapoor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell S. Kapoor's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings134 Last 1 YearsBuy Recommendations80.60% 108 Buy RatingsCompanies Covered32 Unique Companies Ratings Distribution134RatingsDistribution of strong buy, buy, hold, and sell ratings by Mitchell S. Kapoor.RatingPercentageCount Strong Buy0.0%0 ratings Buy80.6%108 ratings Hold15.7%21 ratings Sell3.7%5 ratingsOut of 134 total stock ratings issued by Mitchell S. Kapoor at HC Wainwright, the majority (80.6%) have been Buy recommendations, followed by 15.7% Hold and 3.7% Sell.Best & Worst CallsBest Call0000.0%KYTXAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TILAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.9% of companies on NASDAQ31 companiesNYSE3.1% of companies on NYSE1 companyMitchell S. Kapoor, an analyst at HC Wainwright, currently covers 32 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare31 companies96.9%Miscellaneous1 company3.1%Mitchell S. Kapoor of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY30 companies93.8%Miscellaneous1 company3.1%PHARMACEUTICALS1 company3.1% Mitchell S. Kapoor's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsIONSIonis Pharmaceuticals9/8/2026Lower Price Target$58.09$100.00Buy$0.0000.00% ROIGENBGenerate Biomedicines9/8/2026Reiterated Rating$15.89$30.00Buy$0.0000.00% ROILEGNLegend Biotech9/4/2026Reiterated Rating$21.75$65.00Buy$0.0000.00% ROITYRATyra Biosciences9/4/2026Reiterated Rating$28.38$45.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/3/2026Reiterated Rating$16.26Neutral$0.0000.00% ROIORKAOruka Therapeutics9/3/2026Reiterated Rating$91.63$120.00Buy$0.0000.00% ROIALMSAlumis9/2/2026Upgrade$9.47$15.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics9/2/2026Reiterated Rating$108.58$115.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics8/31/2026Reiterated Rating$57.72Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical8/31/2026Boost Price Target$65.55$60.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. IONSIonis Pharmaceuticals8/31/2026Reiterated Rating$61.05$115.00Buy$0.0000.00% ROISCTXScribe Therapeutics8/31/2026Initiated Coverage$28.44$60.00Buy$0.0000.00% ROIASNDAscendis Pharma A/S8/27/2026Initiated Coverage$250.25$345.00Buy$0.0000.00% ROIASNDAscendis Pharma A/S8/27/2026Reiterated Rating$249.36$345.00Buy$0.0000.00% ROISMMTSummit Therapeutics8/26/2026Reiterated Rating$13.36Neutral$0.0000.00% ROIINCYIncyte8/20/2026Reiterated Rating$128.47$150.00Buy$0.0000.00% ROIKRROKorro Bio8/20/2026Reiterated Rating$13.95$15.00Buy$0.0000.00% ROISMMTSummit Therapeutics8/18/2026Reiterated Rating$12.64Neutral$0.0000.00% ROIBMRNBioMarin Pharmaceutical8/18/2026Lower Price Target$68.22$59.00Neutral$0.0000.00% ROIRNAAvidity Biosciences8/14/2026Reiterated Rating$12.80$25.00Buy$0.0000.00% ROIALMSAlumis8/14/2026Reiterated Rating$25.02$25.00Neutral$0.0000.00% ROINGNENeurogene8/12/2026Lower Price Target$35.80$65.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics8/7/2026Lower Price Target$18.70$30.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical8/7/2026Boost Price Target$61.46$60.00Neutral$0.0000.00% ROIHALOHalozyme Therapeutics8/7/2026Boost Price Target$85.76$115.00Buy$0.0000.00% ROISMMTSummit Therapeutics8/6/2026Reiterated Rating$13.53Neutral$0.0000.00% ROIRNAAvidity Biosciences8/6/2026Initiated Coverage$11.74$25.00Buy$0.0000.00% ROIORKAOruka Therapeutics8/3/2026Reiterated Rating$96.51$120.00Buy$0.0000.00% ROIEVMNEvommune8/3/2026Reiterated Rating$11.24Neutral$0.0000.00% ROIALMSAlumis8/3/2026Reiterated Rating$28.25$25.00Neutral$0.0000.00% ROIIONSIonis Pharmaceuticals7/30/2026Lower Price Target$54.04$115.00Buy$0.0000.00% ROIINCYIncyte7/29/2026Boost Price Target$129.93$150.00Buy$0.0000.00% ROILEGNLegend Biotech7/28/2026Reiterated Rating$19.27$65.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals7/23/2026Reiterated Rating$54.01Buy$0.0000.00% ROISMMTSummit Therapeutics7/23/2026Reiterated Rating$14.74Neutral$0.0000.00% ROIINCYIncyte7/21/2026Reiterated Rating$115.65$140.00Buy$0.0000.00% ROIDMRADamora Therapeutics, Inc. Common Stock7/21/2026Reiterated Rating$32.99$45.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics7/21/2026Reiterated Rating$77.09$95.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals7/10/2026Lower Price Target$60.16$125.00Buy$0.0000.00% ROIMGTXMeiraGTx7/8/2026Reiterated Rating$14.66$20.00Buy$0.0000.00% ROISam Altman’s $4 Trillion IPO Wave (Ad)Reuters calls it a combination without precedent in U.S. market debuts. Barron's estimates the coming AI IPO wave could be worth 4 trillion dollars, led by OpenAI and Anthropic. Former IPO insider Jason Bodner previously flagged Nvidia before its 7,161% run, Super Micro Computer before its 2,601% run, and The Trade Desk before its 2,572% run. Now he's breaking down how investors can position ahead of the OpenAI and Anthropic IPOs.Click here to see Jason Bodner's full breakdown of the detailsCRSPCRISPR Therapeutics7/8/2026Reiterated Rating$60.77$80.00Buy$0.0000.00% ROIINCYIncyte6/24/2026Reiterated Rating$104.40$140.00Buy$0.0000.00% ROIORKAOruka Therapeutics6/23/2026Reiterated Rating$85.38$120.00Buy$0.0000.00% ROIDMRADamora Therapeutics, Inc. Common Stock6/11/2026Initiated Coverage$20.15$45.00Buy$0.0000.00% ROILYELLyell Immunopharma6/9/2026Reiterated Rating$12.31$45.00Buy$0.0000.00% ROINGNENeurogene6/9/2026Reiterated Rating$28.60$70.00Buy$0.0000.00% ROIINCYIncyte6/9/2026Boost Price Target$103.11$140.00Buy$0.0000.00% ROILEGNLegend Biotech6/3/2026Boost Price Target$36.28$65.00Buy$0.0000.00% ROILYELLyell Immunopharma6/3/2026Reiterated Rating$14.89$45.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics6/3/2026Reiterated Rating$7.86$25.00Buy$0.0000.00% ROIEVMNEvommune5/26/2026Reiterated Rating$22.74$50.00Buy$0.0000.00% ROIKRROKorro Bio5/19/2026Lower Price Target$9.97$15.00Buy$0.0000.00% ROILEGNLegend Biotech5/18/2026Reiterated Rating$27.55$50.00Buy$0.0000.00% ROIORKAOruka Therapeutics5/18/2026Reiterated Rating$61.93$120.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/18/2026Lower Price Target$50.63$50.00Neutral$0.0000.00% ROIALMSAlumis5/15/2026Downgrade$24.63$25.00Neutral$0.0000.00% ROIKYTXKyverna Therapeutics5/15/2026Boost Price Target$10.74$25.00Buy$0.0000.00% ROITYRATyra Biosciences5/14/2026Reiterated Rating$36.18$45.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics5/14/2026Lower Price Target$19.85$35.00Buy$0.0000.00% ROINTLAIntellia Therapeutics5/13/2026Lower Price Target$13.99$25.00Buy$0.0000.00% ROIRNACCartesian Therapeutics5/12/2026Lower Price Target$8.53$25.00Buy$0.0000.00% ROICTMXCytomX Therapeutics5/11/2026Lower Price Target$3.98$11.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/5/2026Reiterated Rating$55.46$55.00Neutral$0.0000.00% ROIINCYIncyte5/4/2026Reiterated Rating$96.91$135.00Buy$0.0000.00% ROISMMTSummit Therapeutics5/4/2026Lower Price Target$16.11$23.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics4/29/2026Boost Price Target$63.86$95.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics4/23/2026Reiterated Rating$10.23$20.00Buy$0.0000.00% ROIIPSCCentury Therapeutics4/21/2026Boost Price Target$2.34$5.00Buy$0.0000.00% ROILEGNLegend Biotech4/21/2026Reiterated Rating$25.07$50.00Buy$0.0000.00% ROISRPTSarepta Therapeutics4/16/2026Reiterated Rating$21.07Sell$0.0000.00% ROILEGNLegend Biotech4/15/2026Reiterated Rating$18.69$50.00Buy$0.0000.00% ROIINCYIncyte4/15/2026Reiterated Rating$97.69$135.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/13/2026Boost Price Target$59.58$70.00Buy$0.0000.00% ROIGENBGenerate Biomedicines4/13/2026Initiated Coverage$11.41$16.00Buy$0.0000.00% ROIALMSAlumis3/30/2026Lower Price Target$24.80$25.00Buy$0.0000.00% ROIPALIPalisade Bio3/26/2026Initiated Coverage$2.00$7.00Buy$0.0000.00% ROIINCYIncyte3/25/2026Reiterated Rating$90.62$135.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics3/25/2026Boost Price Target$13.45$40.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals3/25/2026Boost Price Target$73.05$120.00Buy$0.0000.00% ROIEVMNEvommune3/18/2026Lower Price Target$24.99$50.00Buy$0.0000.00% ROICTMXCytomX Therapeutics3/16/2026Boost Price Target$7.81$17.00Buy$0.0000.00% ROIINCYIncyte3/9/2026Reiterated Rating$95.94$135.00Buy$0.0000.00% ROINTLAIntellia Therapeutics3/3/2026Boost Price Target$15.44$30.00Buy$0.0000.00% ROISRPTSarepta Therapeutics3/2/2026Reiterated Rating$16.76Sell$0.0000.00% ROICBIOCrescent Biopharma3/2/2026Lower Price Target$12.09$22.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical2/25/2026Lower Price Target$62.62$55.00Neutral$0.0000.00% ROISMMTSummit Therapeutics2/24/2026Lower Price Target$16.09$30.00Buy$0.0000.00% ROIINCYIncyte2/11/2026Reiterated Rating$100.05$135.00Buy$0.0000.00% ROIEVMNEvommune2/10/2026Boost Price Target$25.02$65.00Buy$0.0000.00% ROIINCYIncyte2/5/2026Initiated Coverage$102.60$135.00Buy$0.0000.00% ROIGold majors have a big problem (Ad)Newmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet production stayed at 5.9 million ounces, unchanged from 2020. Newmont, Barrick and Agnico all face the same reserve shortage, pushing majors toward acquiring smaller producing miners. Recent deals show the pattern: Rupert Resources jumped 67 percent and G2 Goldfields jumped 79 percent the day their buyouts were announced. Analyst Garrett Goggin has identified four junior miners he believes are next on the shopping list.See the four junior gold miners flagged as potential buyout targetsSMMTSummit Therapeutics2/2/2026Reiterated Rating$14.48$40.00Buy$0.0000.00% ROISRPTSarepta Therapeutics1/27/2026Reiterated Rating$22.80Sell$0.0000.00% ROILEGNLegend Biotech1/22/2026Lower Price Target$20.76$50.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics1/15/2026Reiterated Rating$16.19$25.00Buy$0.0000.00% ROISRPTSarepta Therapeutics1/14/2026Reiterated Rating$21.46Sell$0.0000.00% ROINGNENeurogene1/13/2026Reiterated Rating$17.28$70.00Buy$0.0000.00% ROITILInstil Bio1/7/2026Reiterated Rating$7.03Neutral$0.0000.00% ROIEVMNEvommune1/6/2026Initiated Coverage$15.26$35.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical12/22/2025Boost Price Target$61.15$60.00Neutral$0.0000.00% ROIHALOHalozyme Therapeutics12/19/2025Reiterated Rating$65.11$90.00Buy$0.0000.00% ROILYELLyell Immunopharma11/24/2025Reiterated Rating$19.13$20.00Neutral$0.0000.00% ROIRNACCartesian Therapeutics11/19/2025Lower Price Target$7.62$30.00Buy$0.0000.00% ROINGNENeurogene11/13/2025Boost Price Target$31.08$70.00Buy$0.0000.00% ROIKRROKorro Bio11/13/2025Reiterated Rating$31.42Neutral$0.0000.00% ROICTMXCytomX Therapeutics11/11/2025Boost Price Target$4.19$10.00Buy$0.0000.00% ROINTLAIntellia Therapeutics11/10/2025Lower Price Target$9.52$15.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals11/10/2025Boost Price Target$73.55$110.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics10/27/2025Boost Price Target$7.44$20.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/27/2025Lower Price Target$52.67$55.00Neutral$0.0000.00% ROILXEOLexeo Therapeutics10/21/2025Lower Price Target$9.22$13.00Buy$0.0000.00% ROILEGNLegend Biotech10/17/2025Lower Price Target$32.36$60.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics10/15/2025Reiterated Rating$66.65$90.00Buy$0.0000.00% ROINGNENeurogene10/9/2025Reiterated Rating$28.20$45.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals10/8/2025Reiterated Rating$68.94$95.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics10/2/2025Boost Price Target$74.94$90.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics9/23/2025Reiterated Rating$62.10$80.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/23/2025Reiterated Rating$61.36$95.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics9/22/2025Boost Price Target$77.81$85.00Buy$0.0000.00% ROINTLAIntellia Therapeutics9/19/2025Boost Price Target$16.11$30.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics9/17/2025Boost Price Target$11.13$25.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/16/2025Reiterated Rating$18.94$50.00Buy$0.0000.00% ROITILInstil Bio9/11/2025Reiterated Rating$24.16$125.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/8/2025Reiterated Rating$25.98$50.00Buy$00.0000.00% ROIBMRNBioMarin Pharmaceutical9/8/2025Initiated Coverage$57.77$60.00Neutral$00.0000.00% ROIEDITEditas Medicine9/5/2025Reiterated Rating$2.52$5.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/2/2025Reiterated Rating$23.70$50.00Buy$00.0000.00% ROIIONSIonis Pharmaceuticals9/2/2025Boost Price Target$42.63$95.00Buy$00.0000.00% ROIKYTXKyverna Therapeutics8/29/2025Boost Price Target$3.70$10.00Buy$0.0000.00% ROICBIOCrescent Biopharma8/27/2025Reiterated Rating$14.47$25.00Buy$00.0000.00% ROITILInstil Bio8/27/2025Reiterated Rating$28.41$125.00Buy$0.0000.00% ROISRPTSarepta Therapeutics8/25/2025Reiterated Rating$20.22Sell$00.0000.00% ROIIONSIonis Pharmaceuticals8/22/2025Boost Price Target$43.24$70.00Buy$00.0000.00% ROITYRATyra Biosciences8/22/2025Reiterated Rating$11.70$30.00Buy$00.0000.00% ROIEDITEditas Medicine8/15/2025Boost Price Target$2.96$5.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
